TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol

Journal of Pharmacological Sciences

Volumn 127, Issue 1, 2015, Pages 83-91

  Zhang, Zhiyu ^a,b   Li, Zejuan ^b   Wu, Xiaohui ^a,b   Zhang, Chun Feng ^a,b   Calway, Tyler ^a,b   He, Tong Chuan ^b   Du, Wei ^c   Chen, Jianjun ^b   Wang, Chong Zhi ^a,b   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Gene expression; Human colorectal cancer; Microarray; Panax quinquefolius; Protopanaxadiol; Tumor necrosis factor; Xenograft

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; MESSENGER RNA; PROTEIN P53; PROTOPANAXADIOL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTINEOPLASTIC AGENT; SAPOGENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENETICS; ISOLATION AND PURIFICATION; PANAX; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; PANAX; SAPOGENINS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84924070743     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2014.11.003     Document Type: Article

References (48)

1. S.D. Markowitz, and M.M. Bertagnolli Molecular origins of cancer: Molecular basis of colorectal cancer N Engl J Med 361 2009 2449 2460
2. A. Jemal, E. Ward, and M. Thun Declining death rates reflect progress against cancer PLoS One 5 2010 e9584
3. K. Hara, T. Beppu, M. Kimura, Y. Fujita, T. Takata, and K. Nishio Influence of novel supramolecular substance, [2] rotaxane, on the caspase signaling pathway in melanoma and colon cancer cells in vitro J Pharm Sci 122 2013 153 157
4. J.R. Pollack A perspective on DNA microarrays in pathology research and practice Am J Pathol 171 2007 375 385
5. M. Inokuchi, H. Uetake, Y. Shirota, H. Yamada, M. Tajima, and K. Sugihara Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis Cancer Chemother Pharmacol 53 2004 391 396
6. M.J. Ott Complementary and alternative therapies in cancer symptom management Cancer Pract 10 2002 162 166
7. X. Zhou, J. Lin, Y. Yin, J. Zhao, X. Sun, and K. Tang Ganodermataceae: natural products and their related pharmacological functions Am J Chin Med 35 2007 559 574
8. X.J. Li, and H.Y. Zhang Western-medicine-validated anti-tumor agents and traditional Chinese medicine Trends Mol Med 14 2008 1 2
9. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years J Nat Prod 70 2007 461 477
10. G.J. Du, Q. Dai, S. Williams, C.Z. Wang, and C.S. Yuan Synthesis of protopanaxadiol derivatives and evaluation of their anticancer activities Anticancer Drugs 22 2011 35 45
11. X. Luo, J. Chen, W.X. Song, N. Tang, J. Luo, and Z.L. Deng Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects Lab Invest 88 2008 1264 1277
12. B.C. He, L. Chen, G.W. Zuo, W. Zhang, Y. Bi, and J. Huang Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma Clin Cancer Res 16 2010 2235 2245
13. B.C. He, J.L. Gao, B.Q. Zhang, Q. Luo, Q. Shi, and S.H. Kim Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer Mol Pharmacol 79 2011 211 219
14. H. Asano, T. Horinouchi, Y. Mai, O. Sawada, S. Fujii, and T. Nishiya Nicotine- and tar-free cigarette smoke induces cell damage through reactive oxygen species newly generated by PKC-dependent activation of NADPH oxidase J Pharmacol Sci 118 2012 275 287
15. Y. Jia, Q. Guan, Y. Guo, and C. Du Echinacoside stimulates cell proliferation and prevents cell apoptosis in intestinal epithelial MODE-K cells by up-regulation of transforming growth factor-beta1 expression J Pharmacol Sci 118 2012 99 108
16. R.A. Irizarry, B.M. Bolstad, F. Collin, L.M. Cope, B. Hobbs, and T.P. Speed Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 31 2003 e15
17. T. Karl, R. Pabst, and S. von Horsten Behavioral phenotyping of mice in pharmacological and toxicological research Exp Toxicol Pathol: official journal of the Gesellschaft fur Toxikologische Pathologie 55 2003 69 83
18. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA: Cancer J Clin 64 2014 9 29
19. C.Z. Wang, B. Zhang, W.X. Song, A. Wang, M. Ni, and X. Luo Steamed American ginseng berry: ginsenoside analyses and anticancer activities J Agric Food Chem 54 2006 9936 9942
20. C.Z. Wang, H.H. Aung, M. Ni, J.A. Wu, R. Tong, and S. Wicks Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots Planta Med 73 2007 669 674
21. D.G. Popovich, and D.D. Kitts Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line Arch Biochem Biophys 406 2002 1 8
22. D.G. Popovich, and D.D. Kitts Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells J Biochem Mol Toxicol 18 2004 143 149
23. J. Liu, X. Wang, P. Liu, R. Deng, M. Lei, and W. Chen 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs Bioorg Med Chem 21 2013 4279 4287
24. Y.L. Zhang, R. Zhang, H.L. Xu, X.F. Yu, S.C. Qu, and D.Y. Sui 20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway Am J Chin Med 41 2013 1137 1152
25. W. Wang, E.R. Rayburn, M. Hao, Y. Zhao, D.L. Hill, and R. Zhang Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides Prostate 68 2008 809 819
26. A.G. Musende, A. Eberding, C.A. Wood, H. Adomat, L. Fazli, and A. Hurtado-Coll A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer Anticancer Drugs 23 2012 543 552
27. Y. Kim do, M.W. Park, H.D. Yuan, H.J. Lee, S.H. Kim, and S.H. Chung Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells J Agric Food Chem 57 2009 10573 10578
28. B.C. He, J.L. Gao, X. Luo, J. Luo, J. Shen, and L. Wang Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling Int J Oncol 38 2011 437 445
29. H. Lee, S. Cha, M.S. Lee, G.J. Cho, W.S. Choi, and K. Suk Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia J Immunol 171 2003 5802 5811
30. N.C. Wolff, R.M. McKay, and J. Brugarolas REDD1/DDIT4-independent mTORC1 inhibition and apoptosis by glucocorticoids in thymocytes Mol Cancer Res 12 2014 867 877
31. S. Wang, W. Li, Z. Xue, Y. Lu, K. Narsinh, and W. Fan Molecular imaging of p53 signal pathway in lung cancer cell cycle arrest induced by cisplatin Mol Carcinog 52 2013 900 907
32. D.H. Kim, S.E. Park, M. Kim, Y.I. Ji, M.Y. Kang, and E.H. Jung A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers Cancer 117 2011 4080 4091
33. F. Biagioni, N. Bossel Ben-Moshe, G. Fontemaggi, V. Canu, F. Mori, and B. Antoniani miR-10b∗, a master inhibitor of the cell cycle, is down-regulated in human breast tumours EMBO Mol Med 4 2012 1214 1229
34. J.M. Gudas, M. Payton, S. Thukral, E. Chen, M. Bass, and M.O. Robinson Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers Mol Cell Biol 19 1999 612 622
35. C.E. Caldon, C.M. Sergio, J. Kang, A. Muthukaruppan, M.N. Boersma, and A. Stone Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells Mol Cancer Ther 11 2012 1488 1499
36. Y.H. Jin, J. Choi, S. Shin, K.Y. Lee, J.H. Park, and S.K. Lee Panaxadiol selectively inhibits cyclin A-associated Cdk2 activity by elevating p21WAF1/CIP1 protein levels in mammalian cells Carcinogenesis 24 2003 1767 1772
37. Z. Zhang, G.J. Du, C.Z. Wang, X.D. Wen, T. Calway, and Z. Li Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions Int J Mol Sci 14 2013 2980 2995
38. J.W. Harper, S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.H. Tsai, and P. Zhang inhibition of cyclin-dependent kinases by p21 Mol Biol Cell 6 1995 387 400
39. J. Chen, R.M. McKay, and L.F. Parada Malignant glioma: lessons from genomics, mouse models, and stem cells Cell 149 2012 36 47
40. H.S. Gannon, and S.N. Jones Using mouse models to explore MDM-p53 signaling in development, cell growth, and tumorigenesis Genes Cancer 3 2012 209 218
41. M. Minocha, V. Khurana, B. Qin, D. Pal, and A.K. Mitra Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors Int J Pharm 434 2012 306 314
42. F.C. Kischkel, D.A. Lawrence, A. Chuntharapai, P. Schow, K.J. Kim, and A. Ashkenazi Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 12 2000 611 620
43. J.P. Sheridan, S.A. Marsters, R.M. Pitti, A. Gurney, M. Skubatch, and D. Baldwin Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818 821
44. J.E. Allen, and W.S. El-Deiry Regulation of the human TRAIL gene Cancer Biol Ther 13 2012 1143 1151
45. J. Wiezorek, P. Holland, and J. Graves Death receptor agonists as a targeted therapy for cancer Clin Cancer Res 16 2010 1701 1708
46. M.W. den Hollander, J.A. Gietema, S. de Jong, A.M. Walenkamp, A.K. Reyners, and C.N. Oldenhuis Translating TRAIL-receptor targeting agents to the clinic Cancer Lett 332 2013 194 201
47. S. Bousserouel, J. Le Grandois, F. Gosse, D. Werner, S.W. Barth, and E. Marchioni Methanolic extract of white asparagus shoots activates TRAIL apoptotic death pathway in human cancer cells and inhibits colon carcinogenesis in a preclinical model Int J Oncol 43 2013 394 404
48. J.Y. Lee, K.H. Jung, M.J. Morgan, Y.R. Kang, H.S. Lee, and G.B. Koo Sensitization of TRAIL-induced cell death by 20S-Ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells Mol Cancer Ther 12 2013 274 285